Arkolith/Insider Trading/ALMR/Form 4

Luo Yuling

Chief Executive Officer, DirectorAlamar Biosciences, Inc. (ALMR) · full profile →Form 4 · filed Apr 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
29
8 non-derivative · 21 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2026Grant(A)77K—$01.9M
Apr 20, 2026Conversion(C)1.2M——1.2M
Apr 20, 2026Other(J)1.2M——0
Apr 20, 2026Other(J)1.2M——1.2M
Apr 20, 2026Conversion(C)1.4M——1.5M
Apr 20, 2026Conversion(C)364K——1.9M
Apr 20, 2026Other(J)1.9M——0
Apr 20, 2026Other(J)1.9M——1.9M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 20, 2026Other(J)25K—$025K
Apr 20, 2026Other(J)24K—$00
Apr 20, 2026Other(J)24K—$024K
Apr 20, 2026Other(J)20K—$00
Apr 20, 2026Other(J)20K—$020K
Apr 20, 2026Other(J)28K—$00
Apr 20, 2026Other(J)28K—$028K
Apr 20, 2026Other(J)1.0M—$00
Apr 20, 2026Other(J)1.0M—$01.0M
Apr 20, 2026Other(J)37K—$00
Apr 20, 2026Other(J)37K—$037K
Apr 20, 2026Other(J)42K—$00
Apr 20, 2026Other(J)42K—$042K
Apr 20, 2026Conversion(C)1.0M—$00
Apr 20, 2026Conversion(C)366K—$00
Apr 20, 2026Conversion(C)881K—$00
Apr 20, 2026Conversion(C)1.2M—$00
Apr 20, 2026Other(J)266K—$00
Apr 20, 2026Other(J)266K—$0266K
Apr 20, 2026Other(J)25K—$00
Apr 16, 2026Grant(A)341K—$0341K

Transaction Codes

A
Grant / award
C
Conversion of a derivative
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002126941-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML